I feel an increasing optimism among shareholders (on this
I feel an increasing optimism among shareholders (on this board) based on NP´s last interview. On the one hand, yes, the new details given by NP make it more comprehensive why negotiations have been taking that long. On the other hand, it could just be another smart communicative move by him to soften shareholders´ impatience and lack of content.
The one and only thing that really (!) concerns me - among some minor aspect - is the glaring contradiction between scientific and economic potential of this drug and the value the market grants to CYDY. Is that only due to being listed on OTC? Is this science really real? Is there absolutely no chance of being tricked?
And here we go - investors who are to a certain amount risk-averse would ask themselves exactly those questions. Finally, they would most probably avoid this stock as it sounds too good to be true. That was at least the reactions I experienced when I tried to tell others about this company. A company being able to cure or at least treat HIV, Cancer, NASH etc sitting on OTC and being worth only $200m. *lol* We all know that markets aren´t effective but bargains like that are rarely to be found. So the easiest explanation for CYDY´s massive undervaluation is that it cannot be true.
To make ends meet, I think the most important impact of BLA and a deal would be that the story validates and varifies itself. There will be then a point where there is no doubt about it anymore and I am pretty sure that many investors, who avoid CYDY @30c right now, would buy CYDY if SP was already $1.30. Because then it wouldn´t seem like a bizarre miracle.
1
2
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Atlas-SSI Makes Waves with Linita Acquisition Here's the kind of news that makes an old market hound sit up and take notice. Atlas-SSI, the big cheese in North America for water management solutions, has gone and snagged Linita Design & Manufacturing. Why's this worth talking about? Linita isn't just any player—they've been crafting custom-engineered hydro-mechanical...
Continue Reading
Q32 Bio Steers Forward: New Insights from Chief Results Today's update isn't just another quarterly snooze-fest—it’s a nudge in a crucial direction for Q32 Bio (NASDAQ:QTTB). After a bold brush with the European Academy of Dermatology and Venereology (EADV) Congress 2026, the company laid out a plan and a half, showing its hand with bempikibart for alopecia areata...
Continue Reading
Breaking The Mold Of Traditional Medicine MY DR NOW isn't here to play by the age-old rules. They're slinging open the doors to their newest family medicine clinics and kicking the old Monday-to-Friday scheduling straight to the curb. Every single day of the week, from 8 a.m. to 8 p.m., patients in Sunnyvale and Tucson are getting a dose of healthcare that's all about...
Continue Reading
Strategic Leadership for an Evolving Market Prepare your portfolios, folks. DarioHealth Corp. (NASDAQ:DRIO) is gearing up to ride a seismic shift in healthcare. John R. Palumbo's appointment as Chairman of the Board marks a bold move as Dario looks to dominate the new convergence of consumer-directed and payer-funded healthcare. This isn't just a change of guard; it's a...
Continue Reading
A Bold Step Into the Hydrogen Era Hyundai's really stepping it up at the World Hydrogen Expo 2026. They're not just dipping their toes in the hydrogen pool—they're diving in headfirst, showing off integrated hydrogen solutions that are nothing short of ambitious. Hydrogen Production That's a Real Game Changer This ain't just talk. Hyundai's showcasing modular PEM...
Continue Reading
Greasezilla Steps Up for FOG Processing If there’s one thing that makes dealing with wastewater a greasy business, it’s FOG - fats, oils, and grease. It’s the stuff nightmares are made of for any utility trying to keep their pipes clear and their operations running smooth. Now, Greasezilla is stepping into the spotlight at one of the country's largest wastewater...
Continue Reading
Opportunity Knocks for Budding Portfolio Managers Picture this: You're a student, neck-deep in textbooks and theories, and then bam! You're handed the keys to manage a $100 million portfolio. That's the real-deal opportunity Natixis Investment Managers is dangling with its seventh Students Challenge. Diving Into the Nuts and Bolts Listen up, kids. Applications are open...
Continue Reading
Camtek's Record Performance in Q3 2026 Diving straight into the numbers, Camtek (NASDAQ:CAMT) just posted a staggering $161.3 million in Q3 2026 revenues, marking a 21% jump from the previous quarter. Now, that kind of growth isn't just impressive; it's a wake-up call to any investor still snoozing on semiconductor stocks. They're looking at revenues of around $180...
Continue Reading
Piecing Together the New Sinch and SpaceX Partnership Here's a juicy piece of tech news that might just tickle those investing antennas: Sinch AB's teaming up with the SpaceX Super Intelligence Network as a Marketplace Partner. Let's rip the Band-Aid off about why this development has investors riled and buzzing with expectation. Now, Sinch might not be the first company...
Continue Reading
Old-School Radios Meet Cutting-Edge 5G When I hear about a company linking their old-school tech with shiny new 5G jazz, skepticism kicks in fast. But then comes this announcement: Askey and Icom America are joining forces to bring 5G networks with integrated two-way radio systems to various sectors—like a classic combo meal with a tech twist. The key audience? Utility...
Continue Reading
Top 5 Most Recently Viewed Articles
Akebia's Commitment to Rare Kidney Disease Solutions In a significant advancement for the management of kidney diseases, Akebia Therapeutics, Inc. (Nasdaq: AKBA) has announced the formation of a rare kidney disease pipeline. This initiative highlights the company's sustained commitment to improve the lives of individuals affected by diverse kidney disorders. The pipeline...
Continue Reading
Strengthening Compliance through Innovative Partnerships In an era of constant digital transformation, organizations face escalating challenges in maintaining compliance and optimizing security. The partnership between Coalfire and Vanta is strategically designed to revolutionize compliance processes, making them more efficient and less burdensome for internal teams....
Continue Reading
Introducing the Heart and Kidney Health Screening Program In a significant step towards improving community health, Care Access is launching its Heart & Kidney Health Screening initiative. This program aims to raise awareness and provide essential health checks for various risk factors, particularly focusing on lipoprotein(a), commonly referred to as Lp(a). Research...
Continue Reading
Director of Transense Technologies Boosts His Shareholding LONDON - Transense Technologies plc (AIM: TRT), a leading company in sensor solutions and measurement systems, has seen its Managing Director, Ryan Maughan, expand his shareholding. Recently, Maughan bought 3,025 ordinary shares at a price of 165 pence each, underscoring his confidence in the company's potential....
Continue Reading
Recent Insider Trading Activity at Century Aluminum Notable insider trading activity was reported recently surrounding Century Aluminum involving their Senior Vice President, Matt Aboud. The SEC filings revealed that Aboud sold an impressive 12,027 shares of the company. The total value of this transaction amounted to approximately $279,868. Market Response and Share...
Continue Reading